Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lesion activity and chronic demyelination are the major determinants of brain atrophy in MS
Chenyu Wang, Michael Barnett, Con Yiannikas, et al.
Neurology Neuroimmunology & Neuroinflammation (2019) Vol. 6, Iss. 5
Open Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Association of Brain Atrophy With Disease Progression Independent of Relapse Activity in Patients With Relapsing Multiple Sclerosis
Alessandro Cagol, Sabine Schaedelin, Muhamed Baraković, et al.
JAMA Neurology (2022) Vol. 79, Iss. 7, pp. 682-682
Open Access | Times Cited: 98
Choroid plexus volume in multiple sclerosis predicts expansion of chronic lesions and brain atrophy
Samuel Klistorner, Michael Barnett, John Parratt, et al.
Annals of Clinical and Translational Neurology (2022) Vol. 9, Iss. 10, pp. 1528-1537
Open Access | Times Cited: 55
Evolution of Chronic Lesion Tissue in Relapsing-Remitting Patients With Multiple Sclerosis
Samuel Klistorner, Michael Barnett, John DE Parratt, et al.
Neurology Neuroimmunology & Neuroinflammation (2025) Vol. 12, Iss. 3
Closed Access | Times Cited: 1
Connecting Neuroinflammation and Neurodegeneration in Multiple Sclerosis: Are Oligodendrocyte Precursor Cells a Nexus of Disease?
Morgan W. Psenicka, Brandon C. Smith, Rachel A. Tinkey, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 53
Expansion of chronic lesions is linked to disease progression in relapsing–remitting multiple sclerosis patients
Samuel Klistorner, Michael Barnett, Con Yiannikas, et al.
Multiple Sclerosis Journal (2020) Vol. 27, Iss. 10, pp. 1533-1542
Closed Access | Times Cited: 42
The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
Valentina Mazziotti, Francesco Crescenzo, Ermanna Turano, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Suggestions for improving the design of clinical trials in multiple sclerosis—results of a systematic analysis of completed phase III trials
Sinje Gehr, Thomas Kaiser, Reinhold Kreutz, et al.
The EPMA Journal (2019) Vol. 10, Iss. 4, pp. 425-436
Open Access | Times Cited: 39
Chronic demyelination exacerbates neuroaxonal loss in patients with MS with unilateral optic neuritis
Yuyi You, Michael Barnett, Con Yiannikas, et al.
Neurology Neuroimmunology & Neuroinflammation (2020) Vol. 7, Iss. 3
Open Access | Times Cited: 36
Neurite Orientation Dispersion and Density Imaging in Multiple Sclerosis: A Systematic Review
Homa Seyedmirzaei, Fardin Nabizadeh, Mohammad Hadi Aarabi, et al.
Journal of Magnetic Resonance Imaging (2023) Vol. 58, Iss. 4, pp. 1011-1029
Open Access | Times Cited: 12
Impact of pregnancy on the maternal brain in health and multiple sclerosis
Jessica Shipley, Heidi Beadnall, Helmut Butzkueven, et al.
Journal of Neurology Neurosurgery & Psychiatry (2025), pp. jnnp-335319
Closed Access
Cognitive impairment in NMOSD—More questions than answers
Dominika Czarnecka, Magdalena Oset, Iwona Karlińska, et al.
Brain and Behavior (2020) Vol. 10, Iss. 11
Open Access | Times Cited: 30
Spontaneous remyelination in lesions protects the integrity of surrounding tissues over time in multiple sclerosis
Vito A. G. Ricigliano, Mattéo Tonietto, Mariem Hamzaoui, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 6, pp. 1719-1729
Closed Access | Times Cited: 17
The expansion and severity of chronic MS lesions follows a periventricular gradient
Samuel Klistorner, Michael Barnett, Stuart L. Graham, et al.
Multiple Sclerosis Journal (2022) Vol. 28, Iss. 10, pp. 1504-1514
Open Access | Times Cited: 16
Mechanisms of central brain atrophy in multiple sclerosis
Samuel Klistorner, Michael Barnett, Alexander Klistorner
Multiple Sclerosis Journal (2022) Vol. 28, Iss. 13, pp. 2038-2045
Open Access | Times Cited: 15
Vitamin D deficiency and its association with fatigue and quality of life in multiple sclerosis patients
Yeşim Beckmann, Sabiha Türe, Sule Uysal Duman
The EPMA Journal (2019) Vol. 11, Iss. 1, pp. 65-72
Open Access | Times Cited: 23
Ocrelizumab-treated patients with relapsing multiple sclerosis show volume loss rates similar to healthy aging
Shannon Kolind, Laura Gaetano, Haz-Edine Assemlal, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 6, pp. 741-747
Open Access | Times Cited: 6
Brain microstructural injury occurs in patients with RRMS despite ‘no evidence of disease activity’
Asaff Harel, Dylan Sperling, Maria Petracca, et al.
Journal of Neurology Neurosurgery & Psychiatry (2018) Vol. 89, Iss. 9, pp. 977-982
Closed Access | Times Cited: 17
Multiple sclerosis: structural and functional integrity of the visual system following alemtuzumab therapy
Chenyu Wang, Joshua Barton, Kain Kyle, et al.
Journal of Neurology Neurosurgery & Psychiatry (2021) Vol. 92, Iss. 12, pp. 1319-1324
Open Access | Times Cited: 11
U-fiber diffusion kurtosis and susceptibility characteristics in relapsing–remitting multiple sclerosis may be related to cognitive deficits and neurodegeneration
Dan Luo, Yuling Peng, Qiyuan Zhu, et al.
European Radiology (2023) Vol. 34, Iss. 3, pp. 1422-1433
Closed Access | Times Cited: 4
Bioavailable central nervous system disease-modifying therapies for multiple sclerosis
Hans‐Peter Hartung, Bruce Cree, Michael Barnett, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
MicroRNAs dysregulated in multiple sclerosis affect the differentiation of CG-4 cells, an oligodendrocyte progenitor cell line
Océane Perdaens, Pauline Bottemanne, Vincent Van Pesch
Frontiers in Cellular Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
Quantifying chronic lesion expansion in multiple sclerosis: Exploring imaging markers for longitudinal assessment
Samuel Klistorner, Michael Barnett, John Parratt, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 87, pp. 105688-105688
Closed Access | Times Cited: 1
MRI and laboratory monitoring of disease-modifying therapy efficacy and risks
Michael Barnett, Yael Barnett, Stephen Reddel
Current Opinion in Neurology (2022) Vol. 35, Iss. 3, pp. 278-285
Closed Access | Times Cited: 5
Comparison of brain atrophy in patients with multiple sclerosis treated with first‐ versus second‐generation disease modifying therapy without clinical relapse
Hiroki Masuda, Masahiro Mori, Shuji Hirano, et al.
European Journal of Neurology (2020) Vol. 27, Iss. 10, pp. 2056-2061
Closed Access | Times Cited: 5
Simultaneous T2 and mapping of multiple sclerosis lesions with radial RARE‐EPI
Carl Herrmann, Antje Els, Laura Boehmert, et al.
Magnetic Resonance in Medicine (2021) Vol. 86, Iss. 3, pp. 1383-1402
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top